9,10-dimethyl-1,2-benzanthracene has been researched along with alanine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doi, S; Izawa, M; Katsuki, M; Kimura, M; Nishimura, S; Shindo-Okada, N; Takayama, S | 1 |
| Bristow, RG; Cheung, A; De Stanchina, E; Duncan, G; Elia, AJ; Elledge, SJ; Girard, PM; Hirao, A; Jeggo, PA; Lowe, SW; Mak, TW; Okada, H; Sakai, T; Sarkissian, T; Suda, T; Wakeham, A; Wong, JA | 1 |
2 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and alanine
| Article | Year |
|---|---|
Inhibition of chemical carcinogenesis in vivo by azatyrosine.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Alanine; Animals; Antibiotics, Antineoplastic; Drug Screening Assays, Antitumor; Genes, ras; Methylnitrosourea; Mice; Mutation; Papilloma; Skin Neoplasms; Stomach Neoplasms | 1992 |
Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Alanine; Animals; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Carcinogens; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Cycle; Cell Cycle Proteins; Checkpoint Kinase 2; DNA-Binding Proteins; Dose-Response Relationship, Radiation; Female; Genes, p53; Male; Mice; Mice, Knockout; Models, Biological; Models, Genetic; Mutation; Neoplasms, Experimental; Phosphorylation; Protein Binding; Protein Kinases; Protein Serine-Threonine Kinases; Thymus Gland; Time Factors; Tissue Distribution; Tumor Suppressor Protein p53; Tumor Suppressor Proteins | 2002 |